Suppliers in Middleburg Heights, OH
10 Medicare Suppliers found. Showing 1 - 10
 Giant Eagle Pharmacy #0217 Community/Retail Pharmacy Location: 6869 Southland Dr, Middleburg Heights, Ohio 44130 Phone: (440) 885-3019 |
Shield Healthcare Oh, Inc. Durable Medical Equipment & Medical Supplies Location: 17520 Engle Lake Drive Suite A, Middleburg Heights, Ohio 44130 Phone: (216) 281-4777 |
Walgreens #5031 Durable Medical Equipment & Medical Supplies Location: 7260 Pearl Rd, Middleburg Heights, Ohio 44130 Phone: (440) 886-2353 |
Marc's Pharmacy Pharmacy Location: 6849 Southland Dr, Middleburg Heights, Ohio 44130 Phone: (440) 884-4171 |
Kci Usa Inc Durable Medical Equipment & Medical Supplies Location: 6751 Engle Road, Middleburg Heights, Ohio 44130 Phone: (440) 234-8590 |
Boston Brace International Inc Prosthetic/Orthotic Supplier Location: 17900 Jefferson Park Rd, Middleburg Heights, Ohio 44130 Phone: (440) 236-2525 |
Southwest General Home Infusion Pharmacy Location: 18697 Bagley Rd, Middleburg Heights, Ohio 44130 Phone: (440) 816-4493 |
Thomas And Thomas Optical Shop Medicare Supplier Location: 18660 Bagley Rd, Middleburg Heights, Ohio 44130 Phone: (440) 234-9200 |
Southland Vision Care Medicare Supplier Location: 6879 Southland Dr, Middleburg Heights, Ohio 44130 Phone: (440) 888-3515 |
Lenscrafters #0249 Eyewear Supplier (Equipment, not the service) Location: 6801 Pearl Rd, Middleburg Heights, Ohio 44130 Phone: (513) 765-6623 |
News Archive
Perceived threat, rather than actual events, predict brain adaptation
A study of soldiers who took part in the ISAF mission in Afghanistan between 2008 and 2010 has found that their brains adapt when they are continuously exposed to stress. The perceived threat appears to be the major predictor of brain adaptation, rather than the actual events. In other words, if a roadside bomb goes off right in front of you, the degree to which you perceive this as threatening is what counts. This is what determines how the brain and the stress system adapt.
Halozyme initiates Ultrafast Insulin combination Phase 2 studies with rHuPH20
Halozyme Therapeutics, Inc. today announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the two leading commercially available mealtime analogs: insulin aspart, the active ingredient in NovoLog®, and insulin lispro, the active ingredient in Humalog®.
Jury returns $7M verdict for failure to diagnose and treat cardiac tamponade in bypass surgery patient
A New York State Supreme Court Queens County jury returned a $7,000,000.00 verdict against Patrick Monteleone M.D. and Newell Robinson, M.D. where they failed to diagnose and treat cardiac tamponade (bleeding into the chest) in their patient who underwent cardiac bypass surgery on November 17, 2004.
Researchers build better AI algorithms to screen patients for diabetic eye disease
The ability of artificial intelligence (AI) to help screen patients for a common diabetic eye disease gains momentum with a new study published online today in Ophthalmology, the journal of the American Academy of Ophthalmology.
Aspirin plus clopidogrel unlikely to prevent recurrent strokes and may increase risk of death, bleeding
The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with subcortical stroke according to late-breaking research presented at the American Stroke Association's International Stroke Conference 2012.
› Verified 4 days ago